- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system
Patent holdings for IPC class A61P 1/00
Total number of patents in this class: 7158
10-year publication summary
|
169
|
347
|
399
|
455
|
555
|
583
|
653
|
504
|
517
|
48
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Société des Produits Nestlé S.A. | 9928 |
69 |
| Takeda Pharmaceutical Company Limited | 2710 |
52 |
| The Regents of the University of California | 20355 |
43 |
| DSM IP Assets B.V. | 5479 |
38 |
| Novartis AG | 10494 |
37 |
| Nestec S.A. | 2618 |
37 |
| Cedars-Sinai Medical Center | 1185 |
36 |
| N.V. Nutricia | 1077 |
35 |
| Janssen Pharmaceutica N.V. | 3340 |
31 |
| Glycom A/S | 249 |
30 |
| The Johns Hopkins University | 5772 |
29 |
| F. Hoffmann-La Roche AG | 7893 |
27 |
| Raqualia Pharma Inc. | 121 |
27 |
| Eli Lilly and Company | 3965 |
26 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3355 |
26 |
| Osaka University | 3360 |
25 |
| Centre National de La Recherche Scientifique | 10801 |
24 |
| Astellas Pharma Inc. | 1050 |
24 |
| Janssen Biotech, Inc. | 1612 |
24 |
| AstraZeneca AB | 2833 |
23 |
| Other owners | 6495 |